Pou Chen Corporation (TPE:9904)

Augmedix Income Statement

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	267,559	263,818	246,634	267,497	239,884	249,954
Revenue Growth (YoY)	8.96%	6.97%	-7.80%	11.51%	-4.03%	-20.18%
Cost of Revenue	202,904	198,643	185,523	202,891	181,661	195,203
Gross Profit	64,655	65,175	61,111	64,606	58,223	54,751
Selling, General & Admin	44,745	44,518	45,985	48,527	50,654	51,295
Research & Development	4,772	4,703	4,910	5,483	5,093	5,567
Operating Expenses	49,517	49,221	50,895	54,010	55,747	56,862
Operating Income	15,138	15,954	10,216	10,596	2,476	-2,111
Interest Expense	-2,740	-2,805	-3,288	-2,532	-1,869	-2,407
Interest & Investment Income	2,914	3,001	2,519	1,756	1,651	1,646
Earnings From Equity Investments	9,904	10,158	5,829	7,541	10,977	7,898
Currency Exchange Gain (Loss)	191.08	304.8	89.24	1,391	182.41	-422.6
Other Non Operating Income (Expenses)	2,243	2,291	3,274	2,912	3,154	1,607
EBT Excluding Unusual Items	27,650	28,905	18,639	21,663	16,572	6,209
Gain (Loss) on Sale of Investments	684.3	997.01	890.5	84.05	1,217	538.32
Gain (Loss) on Sale of Assets	22.9	29.76	61.48	-196.3	-229.63	-329.12
Asset Writedown	-	-206.39	-124.78	-119.6	-402.09	-457.13
Pretax Income	28,081	29,726	19,467	21,432	17,157	5,961
Income Tax Expense	6,115	6,290	3,493	4,542	553.29	2,042
Earnings From Continuing Operations	21,965	23,436	15,973	16,889	16,603	3,919
Minority Interest in Earnings	-6,986	-7,400	-5,350	-4,245	-2,164	920.77
Net Income	14,979	16,036	10,624	12,645	14,439	4,840
Net Income to Common	14,979	16,036	10,624	12,645	14,439	4,840
Net Income Growth	4.86%	50.94%	-15.98%	-12.43%	198.32%	-59.08%
Shares Outstanding (Basic)	2,947	2,947	2,947	2,947	2,947	2,947
Shares Outstanding (Diluted)	2,956	2,956	2,954	2,955	2,954	2,952
Shares Change (YoY)	0.03%	0.05%	-0.02%	0.01%	0.08%	-0.04%
EPS (Basic)	5.08	5.44	3.61	4.29	4.90	1.64
EPS (Diluted)	5.07	5.43	3.60	4.28	4.89	1.64
EPS Growth	4.81%	50.83%	-15.89%	-12.47%	198.17%	-59.10%
Free Cash Flow	-829.64	4,233	26,333	17,298	4,440	12,448
Free Cash Flow Per Share	-0.28	1.43	8.91	5.85	1.50	4.22
Dividend Per Share	1.700	1.700	1.100	1.300	1.500	0.500
Dividend Growth	54.55%	54.55%	-15.38%	-13.33%	200.00%	-60.00%
Gross Margin	24.16%	24.70%	24.78%	24.15%	24.27%	21.90%
Operating Margin	5.66%	6.05%	4.14%	3.96%	1.03%	-0.84%
Profit Margin	5.60%	6.08%	4.31%	4.73%	6.02%	1.94%
Free Cash Flow Margin	-0.31%	1.60%	10.68%	6.47%	1.85%	4.98%
EBITDA	24,155	24,954	19,161	20,735	13,629	9,192
EBITDA Margin	9.03%	9.46%	7.77%	7.75%	5.68%	3.68%
D&A For EBITDA	9,017	9,000	8,946	10,139	11,153	11,303
EBIT	15,138	15,954	10,216	10,596	2,476	-2,111
EBIT Margin	5.66%	6.05%	4.14%	3.96%	1.03%	-0.84%
Effective Tax Rate	21.78%	21.16%	17.95%	21.19%	3.23%	34.25%

Updated Mar 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.